COSCIENS Biopharma Inc. Deferred Tax Liabilities
COSCIENS Biopharma Inc. (CSCIF) had Deferred Tax Liabilities of $1.12 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxLiabilities · last filed 2026-03-25
- 2025-12-31: Deferred Tax Liabilities $1.12M.
- 2024-12-31: Deferred Tax Liabilities $1.32M.
- 2023-12-31: Deferred Tax Liabilities $2.01M; Deferred Tax Liabilities as first filed $143.00K.
- 2022-12-31: Deferred Tax Liabilities $582.00K.
| Period end | Deferred Tax Liabilities | Deferred Tax Liabilities as first filed |
|---|---|---|
| 2025-12-31 | $1.12M 20-F · filed 2026-03-25 | |
| 2024-12-31 | $1.32M 20-F · filed 2026-03-25 | |
| 2023-12-31 | $2.01M 20-F · filed 2025-04-09 | $143.00K 20-F · filed 2024-03-27 |
| 2022-12-31 | $582.00K 20-F/A · filed 2024-07-17 | |
| 2021-12-31 | $981.00K 20-F/A · filed 2024-02-15 | |
| 2020-12-31 | $1.36M 20-F · filed 2022-03-29 | |
| 2019-12-31 | $3.33M 40-F/A · filed 2021-03-29 | |
| 2018-12-31 | $4.41M 20-F · filed 2020-03-31 | |
| 2017-12-31 | $5.51M 20-F · filed 2019-04-01 | |
| 2016-12-31 | $6.21M 20-F · filed 2018-03-28 |